Page last updated: 2024-08-25

ljc 10627 and Gram-Positive Bacterial Infections

ljc 10627 has been researched along with Gram-Positive Bacterial Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ibbotson, T; Perry, CM1
Collins, L; Eliopoulos, GM; Malanoski, GJ; Moellering, RC; Wennersten, C1

Reviews

1 review(s) available for ljc 10627 and Gram-Positive Bacterial Infections

ArticleYear
Biapenem.
    Drugs, 2002, Volume: 62, Issue:15

    Topics: Adult; Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Thienamycins; Tissue Distribution; Treatment Outcome

2002

Other Studies

1 other study(ies) available for ljc 10627 and Gram-Positive Bacterial Infections

ArticleYear
In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:9

    Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Thienamycins

1993